Concepedia

R O'Regan

RO

Statistics

Publications

3

Citations

112

H-Index

3

Active since

2008

Affiliations

University of Illinois Chicago(Current)

R O'Regan is an author at University of Illinois Chicago specializing in medicine, pharmacology, and oncology.

Top concepts

MedicineOncologyPharmacologyBreast CancerCancer TherapyPharmacotherapyRadiation OncologyHealthTumor BiologyCancer Research

Publications per year

2008–2019

3

Publications

3

Multicenter phase I clinical trial of daily and weekly RAD001 in combination with weekly paclitaxel and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab

Fabrice André, Mario Campone, SA Hurvitz et al. · Journal of Clinical Oncology · 2008 · 52 citations

Breast Oncology, Akt/mtor Activation, Weekly Paclitaxel +18

Everolimus in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab and taxanes: A multicenter phase II clinical trial.

Florence Dalenc, Mario Campone, P. Hupperets et al. · Journal of Clinical Oncology · 2010 · 48 citations

Breast Oncology, Liver Involvement, Immunology +16

Abstract OT1-02-01: Phase I trial of bicalutamide and ribociclib in androgen receptor-positive triple negative breast cancer

Marina N. Sharifi, KB Wisinski, ME Burkard et al. · Cancer Research · 2019 · 12 citations

Express Androgen Receptor, Urology, Breast Oncology +13

1–3 of 3